Induces of periodontitis increases salivary orosomucoid levels

Induces of periodontitis increases salivary orosomucoid levels

Aim: Periodontitis is characterized by chronic infection and inflammation in periodontal tissues leading to destruction of dental support tissues. Acute-phase proteins are effective markers for the identification and evaluation of inflammatory diseases including periodontitis. Orosomucoid (ORM) is an acute-phase plasma protein, also called alpha-1-acid glycoprotein, which is inflammation sensitive. The aim of this study was to evaluate and compare the salivary levels of ORM and C-reactive protein (CRP) in individuals with/withoutperiodontal disease.Material and Methods: A total of 90 subjects were divided into two groups of 45 patients each; periodontally healthy and chronic periodontitis. Saliva samples were collected, and clinical periodontal parameters and salivary flow rates were evaluated at baseline. The ORM and CRP levels in the saliva were analyzed with enzyme-linked immunosorbent assay.Results: The periodontal clinical parameters were significantly higher in the chronic periodontitis group when compared to those of the healthy controls (P0.05). However, the CRP and ORM levels in the saliva were significantly higher in the chronic periodontitis patients than in the healthy controls (P

___

  • Pitiphat W, Savetsilp W, Wara-Aswapati N. C-reactive protein associated with periodontitis in a Thai population. J ClinPeriodontol 2008;35:120-5.
  • Pinho Mde N, Oliveira RD, Novaes AB Jr, et al. Relationship between periodontitis and rheumatoid arthritis and the effect of non-surgical periodontal treatment. Braz Dent J 2009;20:355-64.
  • Ziakas A, Gavrilidis S, Giannoglou G, et al. Kinetics and prognostic value of inflammatory -sensitive protein, IL-6, and white blood cell levels in patients undergoing coronary stent implantation. Med Scı Monıt 2009;15:177-84.
  • Hayashi S, Jinbo T, Iguchi K, et al. A comparison of the concentrations of C-reactive protein and α1-acid glycoprotein in the serum of young and adult dogs with acute inflammation. Vet Res Commun 2001;25:117-26.
  • Hochepied T, Berger FG, Baumann H, et al. Alpha-1-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 2003;14:25-34.
  • De Graaf TW, Van Ommen EC, Van der Stelt ME, et al. Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study. J Rheumatol 1994;21:2209-16.
  • Van Dijk W, Havenaar EC, Brinkman-Van Der Linden EC. Alpha1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function. Glycoconj J 1995;12:227-33.
  • Wu YC, Ning L, Tu YK, et al. Salivary biomarker combination prediction model for the diagnosis of periodontitis in a Taiwanese population. J Formos Med Assoc. 2017;9:S0929- 6646.
  • de Souza AB, Okawa RT, Silva CO, et al. Short-term changes on C-reactive protein (CRP) levels after non-surgical periodontal treatment in systemically healthy individuals. Clin Oral Investig 2017;21:477-84.
  • Nakajima T, Honda T, Domon H, et al. Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease. J Periodontal Res 2010;45:116-22.
  • Yamazaki K, Honda T, Oda T, et al. Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 2005;40:53-8.
  • Shaila M, Pai GP, Shetty P. Salivary protein concentration, flow rate, buffer capacity and pH estimation: A comparative study among young and elderly subjects, both normal and with gingivitis and periodontitis. J Indian Soc Periodontol 2013;17:42-6.
  • Kaufman E, Lamster IB. Analysis of saliva for periodontal diagnosis A review. J Clin Periodontol 2000;27:453-65.
  • Buduneli N, Özçaka Z, Nalbantsoy A. Salivary and plasma levels of toll-like receptor 2 and toll-like receptor 4 in chronic periodontitis. J Periodontol 2011;82:878-84.
  • Gümüş P, Nizam N, Nalbantsoy A, et al. Saliva, and serum levels of Pentraxin-3 and interleukin-1β in generalised aggressive or chronic periodontitis. J Periodontol 2014;85:40-6.
  • Miller CS, King CP Jr, Langub MC, et al. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 2006;137:322-9.
  • Zhang W, Du Y, Wang ML. Noninvasive glucose monitoring using saliva nano-biosensor. Sensing and Bio-Sensing Research 2015;4:23-9.
  • Glurich I, Grossi S, Albini B, et al. Systemic inflammation in cardiovascular and periodontal disease: comparative study. Clin Diagn Lab Immunol 2002;9:425-32.
  • Navazesh M, Kumar SK. Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 2008;139:35-40.
  • Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993;694:72-7.
  • Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229-35.
  • Löe H, Silness J. Periodontal disease in pregnancy. I. prevalence and severity. Acta Odontol Scand 1963;21:533-51.
  • Silness J, Löe H. Periodontal disease in pregnancy. II. correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-35.
  • Armitage GC. Development of a Classification System for Periodontal Diseases and Conditions. Ann Periodontol 1999;4:1-6.
  • Luo Z, Lei H, Sun Y, et al. Orosomucoid, an acute response protein with multiple modulating activities. J Physıol Bıochem 2015;71:329-40.
  • Rangé H, Poitou C, Boillot A, et al. Orosomucoid, a new biomarker in the association between obesity and periodontitis. PLoS One 2013;8:e57645.
  • Berntsson J, Östling G, Persson M, et al. Orosomucoid, carotid plaque, and incidence of stroke. Stroke 2016;47:1858-63.
  • Irmak S, Oliveira-Ferrer L, Singer BB, et al. Proangiogenic properties of orosomucoid (ORM).Exp Cell Res 2009;1:315:3201-9.
  • Fournier T, Medjoubi-n N, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta 2000;18:157-71.
  • Shojaee M, Fereydooni Golpasha M, Maliji G, et al. C - reactive protein levels in patients with periodontal disease and normal subjects. Int J Mol Cell Med 2013;2:151-5.
  • Passos-Soares JS, Gomes-Filho IS, Coelho JMF, et al. Severe chronic periodontitis and C-reactive protein levels. Rev. Saúde Col. UEFS, Feira de Santana 2016;6:1-7.
  • Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35:277-90.
  • Ebersole JL, Kryscio RJ, Campbell C, et al. Salivary and serum adiponectin and C-reactive protein levels in acute myocardial infarction related to body mass index and oral health. J Periodontal Res 2017;52:419-27.
  • Chandy S, Joseph K, Sankaranarayanan A, et al. Evaluation of C-reactive protein and fibrinogen in patients with chronic and aggressive periodontitis: a clinico-biochemical study. J Clin Diagn Res 2017;11:ZC41-ZC5.
  • Sanz M, D’Aiuto F, Deanfield J, et al. European workshop in periodontal health and cardiovascular disease-scientific evidence on the association between periodontal and cardiovascular diseases: A review of the literature. Eur Heart 2010;12:B3-12.
  • Cavalla F, Biguetti CC, Melchiades JL, et al. Genetic association with subgingival bacterial colonization in chronic periodontitis. Genes 2018;9:271.